Do the price regulation and reimbursement affect public expenditures for medicinal products?
Background: Slovenia aims to regulate and reimburse prices of medicinal products in order to manage and reduce public expenditure for medicinal products. Two levels of reference prices (R) are used: external R with a regulated maximum price and internal R with a maximum attributed value, defin...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Slovenian Medical Association
2012-09-01
|
| Series: | Zdravniški Vestnik |
| Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/589 |